Simyra  is a genus of moths of the family Noctuidae. The genus was described by Ochsenheimer in 1816. Species
Simyra nervosa (Denis & Schiffermüller, 1775) central and southern Europe
Simyra albovenosa (Goeze, 1781) Europe, Turkey, northern Iran, Transcaucasia, Central Asia, southern Siberia
Simyra dentinosa Freyer, 1838 south-eastern Europe, Turkey, Caucasus, Transcaucasia, Lebanon, Syria, Israel, Egypt, Iran
Simyra albicosta Hampson, 1909 Nilgiri Mountains of India
Simyra capillata Wallengren, 1875 South Africa
Simyra confusa (Walker, 1856) Sri Lanka, Arabia
Simyra conspersa Moore, 1881 Punjab, Sikkim, Bengal
Simyra renimaculata (Osthelder, 1932) Turkey
Simyra saepestriata (Alphéraky, 1895) Japan, Korea, Mongolia
Simyra sincera Warren, 1914
Simyra splendida Staudinger, 1888 Turkestan, Tibet, southern Siberia, Korea
Simyra insularis (Herrich-Schäffer, 1868) Ontario, New York, Massachusetts, Kansas, California, New Mexico, Cuba
Simyra unifacta Dyar, 1912 Mexico


== References ==
If the delivery has been planned then antigen negative platelets should be available in case the infants platelet count is low on a cord blood sample. After birth
The most rapidly effective treatment in infants with severe hemorrhage and/or a very low platelet count (<30,000  μL−1) is the transfusion of compatible platelets (i.e. platelets from a donor who, like the mother, lacks the causative antigen). If  antigen negative platelets are unavailable, then standard neonatal platelet transfusions should be given until antigen negative platelets become available. If a platelet transfusion is not available immediately then the infant can be given IVIG (1g/kg) however, this will have no effect on the platelet count before 24 to 72 hours.A platelet transfusion is required immediately if there is severe or life-threatening bleeding. If life-threatening bleeding occurs, for example an intracranial hemorrhage, then the platelet count needs to be increased to decrease the risk of further bleeding (> 100,000  μL−1).Any infant with suspected NAIT should have an ultrasound of the head within the first 24 hours after birth to make sure that there is no evidence of an intracranial hemorrhage.If the infant has a platelet count >30,000  μL−1 and no evidence of bleeding, then the baby can be monitored with blood counts until the blood counts return to normal, without the need for any additional treatment. In the past, infusions of IVIG (1 g/kg/day for two days) have been given to the infant and have been shown to rapidly increase the platelet count.